AGP Picks
View all

Africa News Guide
Provided by AGP

Africa News Guide: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Guide.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 5, 2026

Cogent Biosciences Reports Recent Business Highlights and First Quarter 2026 Financial Results
May 5, 2026

Cogent Biosciences Reports Recent Business Highlights and First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Neuronetics Reports First Quarter 2026 Financial and Operating Results
May 5, 2026

Neuronetics Reports First Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire
BridgeBio to Present Primary Results from the Phase 3 CALIBRATE Trial at 2026 ECE
May 5, 2026

BridgeBio to Present Primary Results from the Phase 3 CALIBRATE Trial at 2026 ECE

Indeterminate GlobeNewswire
NIOB Expands Pegmatite System with Encouraging Niobium and Rare Earth Exploration Indicators
May 5, 2026

NIOB Expands Pegmatite System with Encouraging Niobium and Rare Earth Exploration Indicators

Indeterminate GlobeNewswire
Fancamp Exploration Appoints Blake Rhodes to its Board of Directors
May 5, 2026

Fancamp Exploration Appoints Blake Rhodes to its Board of Directors

Indeterminate GlobeNewswire
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 5, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 5, 2026

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026
May 5, 2026

Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026

Indeterminate GlobeNewswire
Electra Therapeutics Announces First Patient Dosed in Phase 1 Study of Ipsoprubart (ELA026) in T Cell Malignancies
May 5, 2026

Electra Therapeutics Announces First Patient Dosed in Phase 1 Study of Ipsoprubart (ELA026) in T Cell Malignancies

Indeterminate GlobeNewswire
Ocular Therapeutix™ Reports First Quarter 2026 Financial Results and Business Highlights
May 5, 2026

Ocular Therapeutix™ Reports First Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire
Rhythm Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update
May 5, 2026

Rhythm Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire
Shopify Delivers Again as Merchants Clear $100 Billion in Q1 GMV
May 5, 2026

Shopify Delivers Again as Merchants Clear $100 Billion in Q1 GMV

Indeterminate GlobeNewswire
Morocco Strategic Closes Private Placement for a Total Amount of $7.5 Millions
May 5, 2026

Morocco Strategic Closes Private Placement for a Total Amount of $7.5 Millions

Indeterminate GlobeNewswire
Corporation de mineraux strategiques du Maroc clôture un placement privé pour un montant total de 7,5 M$
May 5, 2026

Corporation de mineraux strategiques du Maroc clôture un placement privé pour un montant total de 7,5 M$

Indeterminate GlobeNewswire
Fortrea Reports First Quarter 2026 Results
May 5, 2026

Fortrea Reports First Quarter 2026 Results

Indeterminate GlobeNewswire
Latest Findings from DME AWARE Delphi Study Presented at ARVO 2026 Annual Meeting
May 5, 2026

Latest Findings from DME AWARE Delphi Study Presented at ARVO 2026 Annual Meeting

Indeterminate GlobeNewswire
Cytospire Therapeutics announces oversubscribed £61 million ($83m) Series A financing to advance pipeline of first-in-class pan-gamma delta T cell engagers into clinical trials for the treatment of cancer
May 5, 2026

Cytospire Therapeutics announces oversubscribed £61 million ($83m) Series A financing to advance pipeline of first-in-class pan-gamma delta T cell engagers into clinical trials for the treatment of cancer

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Africa News Guide

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.